Korro Bio, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 14.315 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 210.80M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company’s lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson’s disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Details
| Name | Korro Bio, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 57 |
| Founded | 2014 |
| Ipo Date | 2019-10-03 |
| Ceo | Ram Aiyar |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 14.00 |
| Isin | US5009461089 |
| Cusip | 500946108 |
| Cik | 1703647 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Dr. Ram Aiyar MBA, Ph.D. | Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer and Director |
| Dr. Jean-Francois Formela M.D., MBA | Co-Founder and Director |
| Dr. Loic Vincent Ph.D. | Chief Scientific Officer |
| Dr. Jeffrey M. Cerio J.D., Pharm.D. | Senior Vice President, General Counsel and Corporate Secretary |
| Dr. Andrew Fraley Ph.D. | Co-Founder and Advisor |
| Dr. Joshua Rosenthal Ph.D. | Co-Founder and Advisor |
| Todd Chappell M.B.A. | Chief Operating Officer |
| Oliver Dolan | Senior Vice President of Finance and Principal Accounting Officer |
| Stephanie Engels | Chief People Officer |
| Dr. Gaozhong Zhu Ph.D. | SVice President of Chemistry, Manufacturing and Controls and Technical Operations |
Contact
| Address | 60 First Street, 2nd Floor, Cambridge, Massachusetts 02141, United States |
| Phone | 617 468 1999 |
| Website | https://www.korrobio.com |